1 | 164650-45-7 | S,S-艾菲康唑 | S,S-Efinaconazole | C18H22F2N4O
| | |
2 | 2055038-60-1 | Efinaconazole Impurity 12 | Efinaconazole Impurity 12 | C18H22F2N4O
| | |
3 | 105565-56-8 | alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol | alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol | C18H22F2N4O
| | |
4 | | (R)-1-(4-Fluorophenyl)-4-[4-(5-fluoro-2-pyrimidinyl)piperazino]-1-butanol | (R)-1-(4-Fluorophenyl)-4-[4-(5-fluoro-2-pyrimidinyl)piperazino]-1-butanol | C18H22F2N4O
| | |
5 | 164650-44-6 | 艾氟康唑 | (R,R)-2-(2,4-Difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(1,2,4-triazol-1-yl)-2-butanol | C18H22F2N4O
| 原料;原料药;医药原料;医用原料;化学试剂;有机中间体;医药原料药;中药对照品;小分子抑制剂;精细化工产品 | |
6 | 164905-19-5 | (2R,3R)-2-(2,4-DIFLUOROPHENYL)-3-(4-METHYLIDENEPIPERIDIN-1-YL)-1-(1,2,4-TRIAZOL-1-YL)BUTAN-2-OL | (2R,3R)-2-(2,4-DIFLUOROPHENYL)-3-(4-METHYLENEPIPERIDIN-1-YL)-1-(1H-1,2,4-TRIAZOL-1-YL)BUTAN-2-OL | C18H22F2N4O
| | |
7 | 2122222-10-8 | 艾氟康唑杂质09 | 1-Piperidineethanol, α-(2,4-difluorophenyl)-β-methyl-4-methylene-α-(4H-1,2,4-triazol-4-ylmethyl)-, (αR,βR)- | C18H22F2N4O
| | |
8 | 2252350-12-0 | 艾氟康唑杂质22 | 1(2H)-Pyridineethanol, α-(2,4-difluorophenyl)-3,6-dihydro-β,4-dimethyl-α-(1H-1,2,4-triazol-1-ylmethyl)-, (αR,βR)- | C18H22F2N4O
| | |
9 | 2252350-11-9 | (2R,3R)-3-((1H-1,2,4-Triazol-1-yl)methyl)-6-fluoro-3-hydroxy-2-methyl-4''-methylenespiro[indoline-1,1''-piperidin]-1-ium fluoride | (2R,3R)-3-((1H-1,2,4-Triazol-1-yl)methyl)-6-fluoro-3-hydroxy-2-methyl-4''-methylenespiro[indoline-1,1''-piperidin]-1-ium fluoride | C18H22F2N4O
| | |